Skin Disease Education Foundation's (SDEF's) 42nd Annual Hawaii Dermatology Seminar is organized by Global Academy For Medical Education and will be held during Feb 04 - 09, 2018 at Grand Hyatt Kauai Resort and Spa, Kauai, Hawaii, United States of America.
The target audience for this medical event for dermatologists, residents, family physicians, internists, fellows and other physicians, nurse practitioners, physician assistants, and nurses who will gain important insights into the management of patients with skin diseases. This CME Conference has been approved with a maximum of 34 AMA PRA Category 1 Credits.
Course Description:
The latest advances in the treatment and management of common and complex skin diseases of the skin, both for adults and children as well as new developments in aesthetic medicine.
Our exceptional faculty will present clinically relevant information that you will find immediately useful in the care of your patients. This six-day meeting provides interactive presentations, case studies, live-patient injection sessions, and multiple workshops.
SDEF's 42nd annual Hawaii Dermatology Seminar's comprehensive agenda contains cutting edge, innovative, and evolving issues relevant to practicing physicians and health care providers who treat diseases of the skin. The scientific program has been designed to keep the clinician up-to-date with new developments within the field of dermatology.
Learn from the experts about rosacea, acne, psoriasis, melanoma, actinic nonmelanoma skin cancers, atopic dermatitis, onycomycosis, nonsurgical facial rejuventation, pediatric dermatology-focused sessions and much more.
Learning Objectives are :
• Integrate into daily practice evidence-based recommendations on new and emerging therapies for common dermatologic diseases.
• Implement updated strategies for managing acne, rosacea, atopic dermatitis, contact dermatitis and actinic keratosis.
• Explain the roles of currently available biologic agents in the treatment of psoriasis and psoriatic arthritis, and appropriately incorporate newer biologics into therapeutic practice as these become available.
• Describe the mechanisms of action, efficacy, and safety of the biologic agents used to treat psoriasis, as well as the factors involved in appropriate patient selection.
• Assess patients for comorbidities and manage psoriasis as well as associated comorbidities.
Integrate into daily practice new clinical developments and up-to-date guidelines for the management of rheumatoid arthritis (RA) and other immune-mediated inflammatory rheumatologic diseases.
• Analyze treatment approaches for the pediatric patient with common as well as complex skin diseases.
• Incorporate the recent research advances in understanding and treating pediatric dermatology issues such as atopic dermatitis and pediatric acne.
• Discuss new approaches to therapy including pathway targeted therapy in the treatment of melanoma.
Additional details will be posted as soon as they are available.